| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/15/2004 | CN1529704A 3-(4-amidopyrrol-2-2ylmethlidene)-2-indolinone derivatives as protein kinase inhibitors |
| 09/15/2004 | CN1529701A Tocopherols, tocotrienols, other chroman and side chain dervative and uses thereof |
| 09/15/2004 | CN1529699A Novel sulfonic acid derivatives |
| 09/15/2004 | CN1529697A Tricyclic compounds useful as angiotensin II agonists |
| 09/15/2004 | CN1529619A Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enbancing agents |
| 09/15/2004 | CN1529614A Method of reducing side effects of chemotherapy in cancer patient |
| 09/15/2004 | CN1529613A Method for using nervous thread proteins to treat tumors and other conditions requiring removal of destruction of cells |
| 09/15/2004 | CN1529598A Method of treating demyelinating diseases or conditions |
| 09/15/2004 | CN1529595A 4,5-hydro-1H-pyrazole derivative having protent CB1-antagonistic |
| 09/15/2004 | CN1529594A Injectable galenic formulation for use in diagnosis or photodynamic therapy and method for preparing same |
| 09/15/2004 | CN1529590A Compositions and methods to treat neovascularization and disease associated with thereof |
| 09/15/2004 | CN1529551A Substantially homogeneous bio-affecting material having predetermined ratio of bio-affecting component to cell targeting component, method for making such material and use |
| 09/15/2004 | CN1528781A Novel anticancer compound intercedenside D-H in mensamaria intercedens |
| 09/15/2004 | CN1528776A Biomolecule with therapeutic tumour action and its use |
| 09/15/2004 | CN1528775A Oligonucleotide and adriacin covalent coupled compound and preparing method thereof |
| 09/15/2004 | CN1528767A Chinese medicine gelsmium elegans total alkaloid for anticancer and analgesia, and medicinal composition containing it and preparing method thereof |
| 09/15/2004 | CN1528452A Method for preparing broad spectrum genetically engineered nano vaccine for malignant tumour |
| 09/15/2004 | CN1528409A Anticancer medicine |
| 09/15/2004 | CN1528389A Sarcandra powder injection and preparing method thereof |
| 09/15/2004 | CN1528362A Complex anticancer medicine and preparing method thereof |
| 09/15/2004 | CN1528348A Method for preparing novel anti-cancer medicine |
| 09/15/2004 | CN1528339A Chitin soft capsule and preparing method thereof |
| 09/15/2004 | CN1528337A Lentinan drop pill and preparing method thereof |
| 09/15/2004 | CN1528334A Use of anthracene-ring derivatives for preparing medicine to treat brain tumor |
| 09/15/2004 | CN1528282A Use of tauring for preparine medicine enhancing leucocyte function |
| 09/15/2004 | CN1528277A Ubenimex drop pill and preparing method thereof |
| 09/15/2004 | CN1166686C New human protein with the function of inhibiting cancer cell growth and its coding sequence |
| 09/15/2004 | CN1166673C 5-fluro-1-calcium phosphate-uracil |
| 09/15/2004 | CN1166658C 4,5-diaryl-3(i(2H))-furanone derivatives as cyclooxygenase-2 inhibitors |
| 09/15/2004 | CN1166654C Benzoylguanidine derivatives wit advantageous properties, method for producing them and their use in production of medicaments |
| 09/15/2004 | CN1166651C Anti-inflammatory and antineoplastic R-bis or glycophenylpropane isoselenazole substituted compound |
| 09/15/2004 | CN1166645C Bicyclic heterocyles, medicaments contg. these compounds, their use and methods for prodn. thereof |
| 09/15/2004 | CN1166641C New cycloheplene compound, its preparation method and medicine composition containing same |
| 09/15/2004 | CN1166633C New alpha-amino acid sulfuryl compounds, its preparing method and medicinal composition containing them |
| 09/15/2004 | CN1166597C Nitrogenous group conversion method |
| 09/15/2004 | CN1166409C Use of melanoma differentiation associated gene (mda 7) for reversing cancerous phenotype |
| 09/15/2004 | CN1166396C Medicine for auxiliary treating after radiotherapy and chemotherapy of cancer patient |
| 09/15/2004 | CN1166383C Medicine for treating tumor in digestive tract and its prepn |
| 09/15/2004 | CN1166378C 'Tongyuhuazhi' pill |
| 09/15/2004 | CN1166366C Process for producing composite preparation containing nucleic acid |
| 09/14/2004 | US6790989 Interleukin-1 beta converting enzyme/caspase; for prolonging viability of organs/cells for transplantation; for treating inflammatory, autoimmnune and neurodegenerative diseases; prevention of ischemic injury |
| 09/14/2004 | US6790979 Use as antitumor agents, particularly for the treatment of cancers such as colon, skin and prostate cancer and to induce androgen receptor antagonist activity in subject with androgen-related affliction |
| 09/14/2004 | US6790966 Having antineoplastic activity; antioxidant activity; and inhibit dna topoisomerase ii enzyme |
| 09/14/2004 | US6790963 E-isomeric fullerene derivatives |
| 09/14/2004 | US6790953 Ether compounds |
| 09/14/2004 | US6790941 Zinc finger protein derivatives and methods therefor |
| 09/14/2004 | US6790939 Anti-PSCA antibodies |
| 09/14/2004 | US6790860 Pyrrolidine derivatives |
| 09/14/2004 | US6790852 Heterocyclic nitrogen compounds such as 2-(2,6-dichlorophenyl) -4-(3-bromophenyl)-5-(2-(3- hydroxypropylamino)pyrimidin-4-yl) -n-h-imidazole, used as tyrosine kinase inhibitors; anticarcinogenic or antitumor agents |
| 09/14/2004 | US6790843 C-19-halogen-substituted steroids of the androst-9(11)-ene-series, methods for the production and use thereof |
| 09/14/2004 | US6790842 11β LONG-CHAIN SUBSTITUTED ESTRATRIENES, METHOD FOR THEIR PRODUCTION, PHARMACEUTICAL PREPARATIONS CONTAINING SAID 11β LONG-CHAIN SUBSTITUTED ESTATRIENES, AND THEIR USE FOR PRODUCING MEDICAMENTS |
| 09/14/2004 | US6790836 Process for preparing indolopyrrolocarbazole derivatives, intermediates therefor, and preparation process of the intermediates |
| 09/14/2004 | US6790827 Bioconjugates and delivery of bioactive agents |
| 09/14/2004 | US6790826 Human haemopoietic maturation factor |
| 09/14/2004 | US6790638 Method for selecting tumours expressing HLA-G, sensitive to anticancer treatment and uses |
| 09/14/2004 | US6790633 Prevents binding of ras protein in malignant cells |
| 09/14/2004 | US6790628 Screening granulocyte colony stimulating factor(g-csf) poly-peptide analogs to use as g-csf replacements or antagonists; sensitizing cells to chemo/radiotherapy; treating hemato-poietic, neurological or reproduction related conditions |
| 09/14/2004 | US6790440 Administration of a reactive oxygen species (ros) inhibitor or scavenger (a histmine or its salt, ester, prodrug and agonist) and at least one monocyte maturation promoting agent (a cytokine) |
| 09/14/2004 | US6790437 Method of treating cancerous tumors with a dendritic-platinate drug delivery system |
| 09/14/2004 | US6790434 Sunscreen agents; mixture of deactivated bacteria and plant extract |
| 09/14/2004 | CA2456569A1 Benzoazine mono-n-oxides and benzoazine 1,4 dioxides and compositions therefrom for the therapeutic use in cancer treatments |
| 09/14/2004 | CA2315826C Carboxyl acid substituted heterocycles as metalloproteinase inhibitors |
| 09/14/2004 | CA2136438C Anthracycline conjugates, their preparation and their use as antitumor agents |
| 09/14/2004 | CA2116829C Use of a pregnane derivative |
| 09/14/2004 | CA2073113C Conjugates |
| 09/10/2004 | WO2004076667A1 Double-strand rna oligonucleotide having effect of inhibiting the expression of cyclin b gene |
| 09/10/2004 | WO2004076658A1 Monoclonal antibody, gene encoding the same, hybridoma, medicinal composition and diagnostic reagent |
| 09/10/2004 | WO2004076657A2 Cell and enzyme compositions for modulating bile acids, cholesterol and triglycerides |
| 09/10/2004 | WO2004076487A1 Antibody and use thereof |
| 09/10/2004 | WO2004076483A1 Transcriptional factor inducing apoptosis in cancer cell |
| 09/10/2004 | WO2004076482A1 Soluble factor secreted by endothelial cells in blood vessels |
| 09/10/2004 | WO2004076460A1 Method for preparing polymorphism of irinotecan hydrochloride |
| 09/10/2004 | WO2004076458A1 Pyrazolo[1,5-a]pyrimidine derivatives |
| 09/10/2004 | WO2004076446A1 Benzothiophene derivative |
| 09/10/2004 | WO2004076445A2 Compounds and methods of treating cell proliferative diseases, retinopathies and arthritis |
| 09/10/2004 | WO2004076444A2 Novel hydroxycoumaranone derivatives as antitumor and antimetastatic |
| 09/10/2004 | WO2004076441A1 Process for producing acid adduct salt of polyacidic base compound |
| 09/10/2004 | WO2004076424A1 Heterocyclic kinase inhibitors |
| 09/10/2004 | WO2004076410A2 Polymorphs of pyrrole substituted 2-indolinone protein kinase inhibitors |
| 09/10/2004 | WO2004076386A2 Carbamic acid compounds comprising a bicyclic heteroaryl group as hdac inhibitors |
| 09/10/2004 | WO2004075989A1 Fumed silica embolic compositions |
| 09/10/2004 | WO2004075906A1 Antiinflammtory agent and antiinflammatory medical material |
| 09/10/2004 | WO2004075904A1 Method for treating liver cancer by intrahepatic administration of nemorubicin |
| 09/10/2004 | WO2004075890A1 Medicinal composition containing stabilized imidazole derivative and method of stabilizing imidazole derivative |
| 09/10/2004 | WO2004075887A1 Use of 1-(2-chloroethyl)-1-nitroso-3-(2-hydroxyethyl)-urea for the treatment of pancreatic cancer, soft-tissue sarcoma, testicular tumors, lymphoma, thymoma, wilm's tumors, renal carcinoma, melanoma, lung cancer, intracerebral metastasis, tumors in the head and neck region, and mammary carcinoma |
| 09/10/2004 | WO2004075884A1 Therapeutic compositions |
| 09/10/2004 | WO2004075834A2 Stabilized pharmaceutical compositions of safingol and methods of using the same |
| 09/10/2004 | WO2004060261A3 Novel factor viia inhibiting compounds |
| 09/10/2004 | WO2004056832A3 Epothilone derivatives |
| 09/10/2004 | WO2004052847A3 Tricyclic steroid hormone nuclear receptor modulators |
| 09/10/2004 | WO2004043222A3 Treating carcinoid neoplasms with therapeuthic viruses |
| 09/10/2004 | WO2004029287A3 Polypeptides and nucleic acids encoding these and their use for the prevention, diagnosis or treatment of liver disorders and epithelial cancer |
| 09/10/2004 | WO2004014352A3 Methods for treating carbonic anhydrase mediated disorders |
| 09/10/2004 | WO2004009030A3 Angiogenesis inhibition by cephalotaxine alkaloids, derivatives, compositions and uses thereof |
| 09/10/2004 | WO2003106970A3 P27 prevents cellular migration |
| 09/10/2004 | WO2003076579A3 Cancer-linked gene as target for chemotherapy |
| 09/10/2004 | WO2003061652A8 3-(imidazolyl)-2-alkoxypropanoic acids as tafia inhibitors |
| 09/10/2004 | WO2003045230A3 Novel compositions and methods for cancer |
| 09/10/2004 | WO2003038129A3 Methods for assessing and treating leukemia |
| 09/10/2004 | WO2003003979A3 Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions |